Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Fernando Hernandez-Navarro"'
Autor:
Francisco Velasco, Manuel Quintana, C. Lopez-Cabarcos, Mónica Martín-Salces, Víctor Jiménez-Yuste, Fernando Hernandez-Navarro, C. Rodriguez-Merchan, M. T. Alvarez
Publikováno v:
Haemophilia. 15:203-209
The effect of bypassing agents is not as predictable as replacement therapy with the deficient factor in inhibitor patients. Consequently, these patients have more levels of arthropathy than patients without inhibitors. Prophylaxis for inhibitor pati
Autor:
Mónica Martín-Salces, Fernando Hernandez-Navarro, Víctor Jiménez-Yuste, M. T. Alvarez, Manuel Quintana
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 16:209-213
Factor XI deficiency is a rare disease found predominantly in Ashkenazi Jews. There is a poor correlation between factor XI level and bleeding in patients with factor XI deficiency. Individuals with severe factor XI deficiency are usually at risk of
Autor:
E. C. Rodriguez-Merchan, Mónica Martín-Salces, Víctor Jiménez-Yuste, Manuel Quintana, Fernando Hernandez-Navarro, M. T. Alvarez
Publikováno v:
Haemophilia. 14:28-35
Summary. Haemophilia patients with inhibitor have a higher level of arthropathy and more severe joint morbidity than patients without inhibitors. In recent years, interest has grown in the possibility that bypassing agent regimens could prevent bleed
Autor:
Víctor Jiménez-Yuste, Fernando Hernandez-Navarro, R. Fernandez‐Morata, M. T. Alvarez, Manuel Quintana
Publikováno v:
Haemophilia. 14:963-967
Summary. Therapy with factor VIII/von Willebrand factor (FVIII/VWF) concentrate is the mainstay therapy in patients with von Willebrand disease (VWD) unresponsive to desmopressin. There are several commercially available FVIII/VWF concentrates that h
Autor:
Víctor Jiménez-Yuste, E. Carlos Rodríguez-Merchán, Ihosvany Fernandez, Fernando Hernandez-Navarro, Manuel Quintana, M. T. Alvarez
Publikováno v:
Seminars in Hematology. 45:S64-S67
Until recently, orthopedic surgery was strongly contraindicated in patients with hemophilia and inhibitors. However, recent advances in our knowledge of bypassing agents (particularly recombinant activated factor VII [rFVIIa]) that provide effective
Publikováno v:
Bone Marrow Transplantation. 40:1063-1067
Toxicity related to autologous PBSC infusion is well known and traditionally attributed to the presence of DMSO as cryoprotectant. But despite DMSO depletion, adverse events continue appearing. We have conducted a retrospective study to determine the
Autor:
Fernando Hernandez-Navarro, Rosario Madero, J. Coya, Luis Martín-Curto, Beatriz Rodríguez-Vigil, Immaculada Pinilla, Dolores Hernández-Maraver, Nieves Gómez-León
Publikováno v:
British Journal of Haematology. 135:293-302
Hodgkin lymphomas (HL) and non-Hodgkin lymphomas (NHL) are clonal lymphoproliferative diseases that can present with different clinical manifestations that may be difficult to diagnose (Evans & Hancock, 2003; Re et al, 2005). The Ann Summary An accur
Autor:
E Martínez, Víctor Jiménez-Yuste, Eduardo Remor, P. Arranz, J. F. Lucia, R Gonzalez-Boullosa, C Marrero, C Rincón, A Villar, M Quintana, C Sedano, M Prieto, I Soto, J L Diaz, M Moreno, Fernando Hernandez-Navarro, M Garcia-Luaces
Publikováno v:
Haemophilia. 11:603-610
Although there is a worldwide interest in the assessment of health-related quality-of-life (HRQoL) in haemophilia patients, no non-disease specific instruments (for adults) are readily available. In this paper, a haemophilia-specific quality-of-life
Autor:
Víctor Jiménez-Yuste, A. Villar‐Camacho, E González-García, M. Quintana‐Molina, Fernando Hernandez-Navarro, Ihosvany Fernandez-Bello, F Martínez-Bahamonde, J. A. Romero-Garrido
Publikováno v:
Scopus-Elsevier
Surgery in haemophilic patients with inhibitor against factor (F)VIII or FIX is high risk. Surgery may be performed with the administration of sufficiently high dose of FVIII in patients with low-response inhibitor or who, despite having a high respo
Autor:
Manuel Quintana, Jose Gago, Fernando Hernandez-Navarro, Julio Delgado, A. Villar, Víctor Jiménez-Yuste
Publikováno v:
European Journal of Haematology. 69:158-164
Objectives: Acquired hemophilia is a rare disease caused by the development of autoantibodies against factor VIII. Since 1981 we have observed 17 patients with this disorder in our institution. The objective of this survey was to assess the epidemiol